de Geus-Oei LF - Search Results

1

Malignant transformation in an area with elevated F-18 FDG uptake within a low metabolic benign neurofibroma.

van de Luijtgaarden AC, Flucke UE, van der Graaf WT, de Rooy JW, Bonenkamp HJ, de Geus-Oei LF. van de Luijtgaarden AC, et al. Clin Nucl Med. 2010 Apr;35(4):271-2. doi: 10.1097/RLU.0b013e3181d18ff1. Clin Nucl Med. 2010. PMID: 20305421 No abstract available.

2

Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.

van Laarhoven HW, de Geus-Oei LF, Wiering B, Lok J, Rijpkema M, Kaanders JH, Krabbe PF, Ruers T, Punt CJ, van der Kogel AJ, Oyen WJ, Heerschap A. van Laarhoven HW, et al. Radiology. 2005 Oct;237(1):181-8. doi: 10.1148/radiol.2371041397. Radiology. 2005. PMID: 16183932

3

18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.

de Geus-Oei LF, Pieters GF, Bonenkamp JJ, Mudde AH, Bleeker-Rovers CP, Corstens FH, Oyen WJ. de Geus-Oei LF, et al. J Nucl Med. 2006 May;47(5):770-5. J Nucl Med. 2006. PMID: 16644746 Free article.

4

Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.

de Geus-Oei LF, Visser EP, Krabbe PF, van Hoorn BA, Koenders EB, Willemsen AT, Pruim J, Corstens FH, Oyen WJ. de Geus-Oei LF, et al. J Nucl Med. 2006 Jun;47(6):945-9. J Nucl Med. 2006. PMID: 16741303 Free article. Clinical Trial.

5

Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.

de Geus-Oei LF, Kaanders JH, Pop LA, Corstens FH, Oyen WJ. de Geus-Oei LF, et al. Radiother Oncol. 2006 Jul;80(1):51-6. doi: 10.1016/j.radonc.2006.06.001. Epub 2006 Jul 3. Radiother Oncol. 2006. PMID: 16820237

6

Biological correlates of FDG uptake in non-small cell lung cancer.

de Geus-Oei LF, van Krieken JH, Aliredjo RP, Krabbe PF, Frielink C, Verhagen AF, Boerman OC, Oyen WJ. de Geus-Oei LF, et al. Lung Cancer. 2007 Jan;55(1):79-87. doi: 10.1016/j.lungcan.2006.08.018. Epub 2006 Oct 13. Lung Cancer. 2007. PMID: 17046099

7

FDG-PET in colorectal cancer.

de Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ. de Geus-Oei LF, et al. Cancer Imaging. 2006 Oct 31;6(Spec No A):S71-81. doi: 10.1102/1470-7330.2006.9014. Cancer Imaging. 2006. PMID: 17114081 Free PMC article.

8

A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.

Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff ASM, de Geus-Oei LF, Rijnders AJ, Krabbe PFM, Corstens FHM, van der Meer JWM, Oyen WJG. Bleeker-Rovers CP, et al. Eur J Nucl Med Mol Imaging. 2007 May;34(5):694-703. doi: 10.1007/s00259-006-0295-z. Epub 2006 Dec 14. Eur J Nucl Med Mol Imaging. 2007. PMID: 17171357

9

Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.

de Geus-Oei LF, van der Heijden HF, Visser EP, Hermsen R, van Hoorn BA, Timmer-Bonte JN, Willemsen AT, Pruim J, Corstens FH, Krabbe PF, Oyen WJ. de Geus-Oei LF, et al. J Nucl Med. 2007 Oct;48(10):1592-8. doi: 10.2967/jnumed.107.043414. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873138 Free article. Clinical Trial.

10

Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.

Visser EP, Philippens ME, Kienhorst L, Kaanders JH, Corstens FH, de Geus-Oei LF, Oyen WJ. Visser EP, et al. J Nucl Med. 2008 Jun;49(6):892-8. doi: 10.2967/jnumed.107.049585. Epub 2008 May 15. J Nucl Med. 2008. PMID: 18483085 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters